Tag Archives: Patent Law

Innovation Toys And Analogous Art – Defender Against Hindsight?

There is nothing particularly surprising in the recent Fed. Cir. decision of Innovation Toys v. MGA Entertainment, App. No. 2010-1290 (Fed. Cir. March 21, 2011) (a copy is available at the end of this post), which reversed a District Court finding … Continue reading

Posted in Obviousness | Tagged , , , , , , , , , , , , , , , | Leave a comment

One step ahead and one step backward for the EU patent

The following is a contribution from Camilla Rendal Nielsen of Zacco Denmark A/S 1.   The EU Competiveness Council have authorised “enhanced cooperation” in the area of unitary patent protection, and. 2.   The EU court now states that the proposed Patents Court … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , , , , , , , | Leave a comment

Canadian Ruling Supports “Antibody Exception”

In my recent post on the Centocor v. Abbott decision, I noted that the Fed. Cir. had at least preserved the “antibody exception,” which I define as permitting broad claims to structurally uncharacterized antibodies (monoclonal and polyclonal) if the structure … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , , , , , , , , | Leave a comment

Patent Reform Bill Passes Senate – What Will Come To Pass?

Late on March 8th, the Senate almost unanimously passed S. 23, which was only introduced in January. (A copy of the bill is available at the end of this post.) I last commented on the features of this bill in … Continue reading

Posted in Patent Reform Legislation | Tagged , , , , , , , , , | Leave a comment